# Oral Lactobacillus Rhamnosus TCELL-1 and Colorectal Cancer

> **NCT05570942** · PHASE2 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 56 (estimated)

## Conditions studied

- Staged III Colorectal Cancer Receiving Adjuvant Chemotherapy

## Interventions

- **DIETARY_SUPPLEMENT:** Oral Lactobacillus rhamnosus TCELL-1

## Key facts

- **NCT ID:** NCT05570942
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-07
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05570942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05570942, "Oral Lactobacillus Rhamnosus TCELL-1 and Colorectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05570942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*